Incidence of diabetes and its predictors in the Greater Beirut Area: a five-year longitudinal study.
Beirut
Incidence
Lebanon
MENA region
Metabolic syndrome
Predictors
Type 2 Diabetes
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
04 May 2022
04 May 2022
Historique:
received:
21
05
2021
accepted:
11
04
2022
entrez:
5
5
2022
pubmed:
6
5
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Type 2 Diabetes (T2D) remains a world epidemic. Obtaining accurate estimates of its incidence and their predictors will aid in targeting preventive measures, allocating resources, and strategizing its management. The Middle East North Africa region has high T2D prevalence and rates of rise. Few incidence studies exist for the region, and none from Lebanon. The current study objective was to determine diabetes incidence and diabetes predictors in a community-based Lebanese sample. A secondary objective was to describe the metabolic control over time in adults with preexisting diabetes. This is a five-year (2014-2019) follow-up study on a random sample of 501 residents of the Greater Beirut area. Out of 478 people eligible to participate in the follow-up study, 198 returned (response rate 39.5%). Assessment included medical history, anthropometric measures, food frequency, sleep, and lifestyle questionnaires. Laboratory data included glycemic indices (fasting glucose and HbA1C) and other biological markers. The diagnosis of probable diabetes (PD) was based on one abnormal test for either fasting glucose ≥ 126 mg/dL or HbA1C ≥ 6.5% or having history of diabetes. The incidence of diabetes was 17.2 (95% CI 9.6-28.7) per 1000 person-years. Cardiometabolic risk factors independently associated with diabetes were: older age, higher BMI, family history of diabetes, metabolic syndrome, higher CRP and triglyceride level; whereas an independent predictor of diabetes was previous BMI. In addition, the 42 participants with preexisting diabetes had worsening of their metabolic profile over a five-year period. The incidence of diabetes was high as compared to some reported world rates, and in line with the high prevalence in the MENA region. The risk was highest in those with positive family history and the presence of the metabolic syndrome or its components. Preventive measures should particularly target participants with that specific risk profile. This becomes particularly important when observing that metabolic control gets worse over time in individuals with diabetes.
Sections du résumé
BACKGROUND
BACKGROUND
Type 2 Diabetes (T2D) remains a world epidemic. Obtaining accurate estimates of its incidence and their predictors will aid in targeting preventive measures, allocating resources, and strategizing its management. The Middle East North Africa region has high T2D prevalence and rates of rise. Few incidence studies exist for the region, and none from Lebanon. The current study objective was to determine diabetes incidence and diabetes predictors in a community-based Lebanese sample. A secondary objective was to describe the metabolic control over time in adults with preexisting diabetes.
METHODS
METHODS
This is a five-year (2014-2019) follow-up study on a random sample of 501 residents of the Greater Beirut area. Out of 478 people eligible to participate in the follow-up study, 198 returned (response rate 39.5%). Assessment included medical history, anthropometric measures, food frequency, sleep, and lifestyle questionnaires. Laboratory data included glycemic indices (fasting glucose and HbA1C) and other biological markers. The diagnosis of probable diabetes (PD) was based on one abnormal test for either fasting glucose ≥ 126 mg/dL or HbA1C ≥ 6.5% or having history of diabetes.
RESULTS
RESULTS
The incidence of diabetes was 17.2 (95% CI 9.6-28.7) per 1000 person-years. Cardiometabolic risk factors independently associated with diabetes were: older age, higher BMI, family history of diabetes, metabolic syndrome, higher CRP and triglyceride level; whereas an independent predictor of diabetes was previous BMI. In addition, the 42 participants with preexisting diabetes had worsening of their metabolic profile over a five-year period.
CONCLUSIONS
CONCLUSIONS
The incidence of diabetes was high as compared to some reported world rates, and in line with the high prevalence in the MENA region. The risk was highest in those with positive family history and the presence of the metabolic syndrome or its components. Preventive measures should particularly target participants with that specific risk profile. This becomes particularly important when observing that metabolic control gets worse over time in individuals with diabetes.
Identifiants
pubmed: 35509100
doi: 10.1186/s13098-022-00833-w
pii: 10.1186/s13098-022-00833-w
pmc: PMC9066987
doi:
Types de publication
Journal Article
Langues
eng
Pagination
67Informations de copyright
© 2022. The Author(s).
Références
BMC Public Health. 2015 Sep 03;15:855
pubmed: 26334523
Public Health Nutr. 2006 Apr;9(2):194-203
pubmed: 16571173
BMC Med. 2017 Jul 19;15(1):131
pubmed: 28720102
Diabetes Res Clin Pract. 2014 Sep;105(3):408-15
pubmed: 25005850
Diabetes Care. 2007 Oct;30(10):2517-22
pubmed: 17634276
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
J Sci Food Agric. 2018 Jun;98(8):3198-3207
pubmed: 29230816
BMC Public Health. 2019 Jan 31;19(1):140
pubmed: 30704495
Diabetes Res Clin Pract. 2014 Feb;103(2):218-22
pubmed: 24300017
BMC Public Health. 2017 Jul 24;18(1):49
pubmed: 28738790
BMJ. 2019 Sep 11;366:l5003
pubmed: 31511236
Diabetes Care. 2005 May;28(5):1262
pubmed: 15855610
Nutrients. 2020 Oct 29;12(11):
pubmed: 33137973
Nutrients. 2019 Jun 05;11(6):
pubmed: 31195724
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
Endocr Pract. 2017 Sep;23(9):1091-1100
pubmed: 28683240
Environ Monit Assess. 2017 Sep 23;189(10):517
pubmed: 28942470
PLoS One. 2016 Jun 20;11(6):e0157592
pubmed: 27322410
PLoS One. 2014 Jul 16;9(7):e102563
pubmed: 25029368
Diabetes Res Clin Pract. 2011 Mar;91(3):307-15
pubmed: 21168232
Arch Intern Med. 2005 May 9;165(9):997-1003
pubmed: 15883237
JAMA. 2005 Jul 6;294(1):97-104
pubmed: 15998896
Nature. 2006 Dec 14;444(7121):881-7
pubmed: 17167477
N Engl J Med. 2001 Sep 13;345(11):790-7
pubmed: 11556298
JAMA. 2004 Aug 25;292(8):927-34
pubmed: 15328324
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
N Engl J Med. 2007 Jan 18;356(3):213-5
pubmed: 17229948
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
J Environ Public Health. 2012;2012:235618
pubmed: 22013454
J Epidemiol Glob Health. 2014 Dec;4(4):297-302
pubmed: 25455647
Diabetes Care. 2007 Sep;30(9):2258-63
pubmed: 17536076
Ann Thorac Med. 2011 Oct;6(4):212-6
pubmed: 21977066
Glob Heart. 2018 Dec;13(4):275-283
pubmed: 29716848
Public Health Nutr. 2018 Jan;21(1):160-171
pubmed: 28965534
Lancet. 2020 Nov 14;396(10262):1535
pubmed: 33189162
BMC Obes. 2019 Jan 03;6:1
pubmed: 30619612
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S439-S444
pubmed: 28404516
J Diabetes Res. 2020 Jan 20;2020:2597953
pubmed: 32051832
Eur J Clin Nutr. 2012 Aug;66(8):872-7
pubmed: 22713771
Diabetes Care. 2006 Jul;29(7):1579-84
pubmed: 16801582
Aust N Z J Public Health. 2012 Apr;36(2):106-8
pubmed: 22487341
BMJ Open. 2020 Jul 2;10(7):e035813
pubmed: 32616491
Transl Res. 2017 Jun;184:101-107
pubmed: 28336465
Ann Intern Med. 1999 Oct 5;131(7):485-91
pubmed: 10507956
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Diabetes Care. 2014 Feb;37(2):569-86
pubmed: 24459154
Anadolu Kardiyol Derg. 2006 Dec;6(4):314-21
pubmed: 17162275